Symptômes musculaires associés aux statines : quelle prise en charge en 2018 ?
Other titleStatin-associated muscle symptoms : Current management in 2018
Published inRevue médicale suisse, vol. 14, no. 596, p. 462-469
Publication date2018-02-28
Abstract
Keywords
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
- Hyperlipidemias
- Muscular Diseases / chemically induced
- Myalgia / chemically induced
- Myositis / chemically induced
- Rhabdomyolysis / chemically induced
- Rhabdomyolysis / drug therapy
Affiliation Not a UNIGE publication
Research group
Citation (ISO format)
KOSINSKI, Christophe et al. Symptômes musculaires associés aux statines : quelle prise en charge en 2018 ? In: Revue médicale suisse, 2018, vol. 14, n° 596, p. 462–469. doi: 10.53738/REVMED.2018.14.596.0462
Main files (1)
Article (Published version)
Identifiers
- PID : unige:161764
- DOI : 10.53738/REVMED.2018.14.596.0462
- PMID : 29489126
ISSN of the journal1660-9379